Immunological aspects of the complex regional pain syndrome (CRPS)

Current Pharmaceutical Design

Volumn 18, Issue 29, 2012, Pages 4546-4549

  Krämer, Heidrun H ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Autoimmunity; CRPS; Cytokines; Neuropeptides

Indexed keywords

AUTOANTIBODY; CYTOKINE;

AUTOIMMUNITY; COMPLEX REGIONAL PAIN SYNDROME; EDEMA; HUMAN; HYPERALGESIA; IMMUNE RESPONSE; LIMB INJURY; NEUROGENIC INFLAMMATION; PAIN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SKIN COLOR; SKIN TEMPERATURE;

ANIMALS; AUTOANTIBODIES; COMPLEX REGIONAL PAIN SYNDROMES; CYTOKINES; HUMANS; INFLAMMATION MEDIATORS; NEUROGENIC INFLAMMATION;

EID: 84866432394     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161212802502206     Document Type: Review

References (54)

1. Langberg H, Bjorn C, Boushel R, Hellsten Y, Kjaer M. Exerciseinduced increase in interstitial bradykinin and adenosine concentrations in skeletal muscle and peritendinous tissue in humans. J Physiol 2002; 542(Pt 3): 977-983.
2. Steiner G, Studnicka-Benke A, Witzmann G, Hofler E, Smolen J. Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis. J Rheumatol 1995; 22(3): 406-412.
3. Tsiridis E, Upadhyay N, Giannoudis P. Molecular aspects of fracture healing: which are the important molecules? Injury 2007; 38 (Suppl 1): S11-S25.
4. Lee JS, Ryu CH, Moon NH, Kim SJ, Park SY, Suh KT. Changes in serum levels of receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, IL-6 and TNF-alpha in patients with a concomitant head injury and fracture. Arch Orthop Trauma Surg 2009; 129(5): 711-718.
5. Huey KA, McCall GE, Zhong H, Roy RR. Modulation of HSP25 and TNF-alpha during the early stages of functional overload of a rat slow and fast muscle. J Appl Physiol 2007; 102(6): 2307-2314.
6. Grellner W, Georg T, Wilske J. Quantitative analysis of proinflammatory cytokines (IL-1beta, IL-6, TNF-alpha) in human skin wounds. Forensic Sci Int 2000; 113(1-3): 251-264.
7. Birklein F, Schmelz M, Schifter S, Weber M. The important role of neuropeptides in complex regional pain syndrome. Neurology 2001; 57(12): 2179-2184.
8. Harden N, Bruehl S. Diagnostc criteria: the statistical derivation of four criterion factors. In: Wilson P, Stanton-Hicks M, Harden N, Eds. CRPS: current diagnosis and therap. Seattle: IASP Press 2005; pp. 45-58.
9. Birklein F, Riedl B, Neundorfer B, Handwerker HO. Sympathetic vasoconstrictor reflex pattern in patients with complex regional pain syndrome. Pain 1998; 75(1): 93-100.
10. Veldman PH, Reynen HM, Arntz IE, Goris RJ. Signs and symptoms of reflex sympathetic dystrophy: prospective study of 829 patients. Lancet 1993; 342(8878): 1012-1216.
11. Wesseldijk F, Huygen FJ, Heijmans-Antonissen C, Niehof SP, Zijlstra FJ. Tumor necrosis factor-alpha and interleukin-6 are not correlated with the characteristics of Complex Regional Pain Syndrome type 1 in 66 patients. Eur J Pain 2008; 12(6): 716-721.
12. Wesseldijk F, Huygen FJ, Heijmans-Antonissen C, Niehof SP, Zijlstra FJ. Six years follow-up of the levels of TNF-alpha and IL-6 in patients with complex regional pain syndrome type 1. Mediators Inflamm 2008; 2008: 469439.
13. Sabsovich I, Guo TZ, Wei T, et al. TNF signaling contributes to the development of nociceptive sensitization in a tibia fracture model of complex regional pain syndrome type I. Pain 2008; 137(3): 507-519.
14. Weber M, Birklein F, Neundorfer B, Schmelz M. Facilitated neurogenic inflammation in complex regional pain syndrome. Pain 2001; 91(3): 251-257.
15. Blaes F, Tschernatsch M, Braeu ME, et al. Autoimmunity in complex-regional pain syndrome. Ann N Y Acad Sci 2007; 1107: 168-173.
16. Uceyler N, Eberle T, Rolke R, Birklein F, Sommer C. Differential expression patterns of cytokines in complex regional pain syndrome. Pain 2007; 132(1-2): 195-205.
17. Moseley GL. Distorted body image in complex regional pain syndrome. Neurology 2005; 65(5): 773.
18. Schinkel C, Gaertner A, Zaspel J, Zedler S, Faist E, Schuermann M. Inflammatory mediators are altered in the acute phase of posttraumatic complex regional pain syndrome. Clin J Pain 2006; 22(3): 235-239.
19. Kramer HH, Eberle T, Uceyler N, et al. TNF-alpha in CRPS and 'normal' trauma - significant differences between tissue and serum. Pain 2011; 152(2): 285-290.
20. Maihofner C, Handwerker HO, Neundorfer B, Birklein F. Mechanical hyperalgesia in complex regional pain syndrome: a role for TNF-alpha? Neurology 2005; 65(2): 311-313.
21. Munnikes RJ, Muis C, Boersma M, Heijmans-Antonissen C, Zijlstra FJ, Huygen FJ. Intermediate stage complex regional pain syndrome type 1 is unrelated to proinflammatory cytokines. Mediators Inflamm 2005; 2005(6): 366-372.
22. Eberle T, Doganci B, Kramer HH, et al. Warm and cold complex regional pain syndromes: differences beyond skin temperature? Neurology 2009; 72(6): 505-512.
23. Huygen FJ, Niehof S, Zijlstra FJ, van Hagen PM, van Daele PL. Successful treatment of CRPS 1 with anti-TNF. J Pain Symptom Manage 2004; 27(2): 101-103.
24. Schwartzman RJ, Chevlen E, Bengtson K. Thalidomide has activity in treating complex regional pain syndrome. Arch Intern Med 2003; 163(12): 1487-1488; author reply 8.
25. Szolcsanyi J. Capsaicin-sensitive sensory nerve terminals with local and systemic efferent functions: facts and scopes of an unorthodox neuroregulatory mechanism. Prog Brain Res 1996; 113: 343-359.
26. Holzer P. Neurogenic vasodilatation and plasma leakage in the skin. Gen Pharmacol 1998; 30(1): 5-11.
27. Schmelz M, Michael K, Weidner C, Schmidt R, Torebjork HE, Handwerker HO. Which nerve fibers mediate the axon reflex flare in human skin? Neuroreport 2000; 11(3): 645-648.
28. Gee MD, Lynn B, Cotsell B. The relationship between cutaneous C fibre type and antidromic vasodilatation in the rabbit and the rat. J Physiol 1997; 503 (Pt 1): 31-44.
29. Mujenda FH, Duarte AM, Reilly EK, Strichartz GR. Cutaneous endothelin-A receptors elevate post-incisional pain. Pain 2007; 133(1-3): 161-173.
30. Groneberg DA, Serowka F, Peckenschneider N, et al. Gene expression and regulation of nerve growth factor in atopic dermatitis mast cells and the human mast cell line-1. J Neuroimmunol 2005; 161(1-2): 87-92.
31. Gamse R, Posch M, Saria A, Jancso G. Several mediators appear to interact in neurogenic inflammation. Acta Physiol Hung 1987; 69(3-4): 343-354.
32. Saade NE, Massaad CA, Ochoa-Chaar CI, Jabbur SJ, Safieh-Garabedian B, Atweh SF. Upregulation of proinflammatory cytokines and nerve growth factor by intraplantar injection of capsaicin in rats. J Physiol 2002; 545(Pt 1): 241-253.
33. van der Kleij HP, Ma D, Redegeld FA, Kraneveld AD, Nijkamp FP, Bienenstock J. Functional expression of neurokinin 1 receptors on mast cells induced by IL-4 and stem cell factor. J Immunol 2003; 171(4): 2074-2079.
34. Baron R. Peripheral neuropathic pain: from mechanisms to symptoms. Clin J Pain 2000; 16(2 Suppl): S12-S20.
35. Kingery WS, Davies MF, Clark JD. A substance P receptor (NK1) antagonist can reverse vascular and nociceptive abnormalities in a rat model of complex regional pain syndrome type II. Pain 2003; 104(1-2): 75-84.
36. Guo TZ, Offley SC, Boyd EA, Jacobs CR, Kingery WS. Substance P signaling contributes to the vascular and nociceptive abnormalities observed in a tibial fracture rat model of complex regional pain syndrome type I. Pain 2004; 108(1-2): 95-107.
37. Leis S, Weber M, Schmelz M, Birklein F. Facilitated neurogenic inflammation in unaffected limbs of patients with complex regional pain syndrome. Neurosci Lett 2004; 359(3): 163-166.
38. Kramer HH, He L, Lu B, Birklein F, Sommer C. Increased pain and neurogenic inflammation in mice deficient of neutral endopeptidase. Neurobiol Dis 2009; 35(2): 177-183.
39. Groeneweg JG, Huygen FJ, Heijmans-Antonissen C, Niehof S, Zijlstra FJ. Increased endothelin-1 and diminished nitric oxide levels in blister fluids of patients with intermediate cold type complex regional pain syndrome type 1. BMC Musculoskelet Disord 2006; 7: 91.
40. Blaes F, Schmitz K, Tschernatsch M, et al. Autoimmune etiology of complex regional pain syndrome (M. Sudeck). Neurology 2004; 63(9): 1734-1736.
41. Kohr D, Singh P, Tschernatsch M, et al. Autoimmunity against the beta(2) adrenergic receptor and muscarinic-2 receptor in complex regional pain syndrome. Pain 2011; 152(12): 2690-2700.
42. Goebel A, Stock M, Deacon R, Sprotte G, Vincent A. Intravenous immunoglobulin response and evidence for pathogenic antibodies in a case of complex regional pain syndrome 1. Ann Neurol 2005; 57(3): 463-464.
43. Kemler MA, van de Vusse AC, van den Berg-Loonen EM, Barendse GA, van Kleef M, Weber WE. HLA-DQ1 associated with reflex sympathetic dystrophy. Neurology 1999; 53(6): 1350-1351.
44. van Hilten JJ, van de Beek WJ, Roep BO. Multifocal or generalized tonic dystonia of complex regional pain syndrome: a distinct clinical entity associated with HLA-DR13. Ann Neurol 2000; 48(1): 113-116.
45. Mailis A, Wade J. Profile of Caucasian women with possible genetic predisposition to reflex sympathetic dystrophy: a pilot study. Clin J Pain 1994; 10(3): 210-217.
46. van de Beek WJ, Roep BO, van der Slik AR, Giphart MJ, van Hilten BJ. Susceptibility loci for complex regional pain syndrome. Pain 2003; 103(1-2): 93-97.
47. Krämer HH, Schmidt K, Leis S, Schmelz M, Sommer C, Birklein F. Inhibition of neutral endopeptidase (NEP) facilitates neurogenic inflammation. Exp Neurol 2005; 195(1): 179-184.
48. Mentlein R, Roos T. Proteases involved in the metabolism of angiotensin II, bradykinin, calcitonin gene-related peptide (CGRP), and neuropeptide Y by vascular smooth muscle cells. Peptides 1996; 17(4): 709-720.
49. Huehne K, Schaal U, Leis S, et al. Lack of genetic association of neutral endopeptidase (NEP) with complex regional pain syndrome (CRPS). Neurosci Lett 2010; 472(1): 19-23.
50. Kimura T, Komatsu T, Hosada R, Nishiwaki K, Shimada YA, Eds. Angiotensinconverting enzyme gene polymorphism in patients with neuropathic pain. IASP; 2000; Seattle: Proceedings of the ninth World Congress in pain.
51. Huhne K, Leis S, Schmelz M, Rautenstrauss B, Birklein F. A polymorphic locus in the intron 16 of the human angiotensinconverting enzyme (ACE) gene is not correlated with complex regional pain syndrome I (CRPS I). Eur J Pain 2004; 8(3): 221-225.
52. de Mos M, Huygen FJ, Stricker BH, Dieleman JP, Sturkenboom MC. The association between ACE inhibitors and the complex regional pain syndrome: suggestions for a neuro-inflammatory pathogenesis of CRPS. Pain 2009; 142(3): 218-224.
53. de Rooij AM, de Mos M, van Hilten JJ, et al. Increased risk of complex regional pain syndrome in siblings of patients? J Pain 2009; 10(12): 1250-1255.
54. Birklein F. Chapter 35 Complex regional pain syndrome. Handb Clin Neurol 2006; 81: 529-546.